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The three-dimensional structure of fructose-1,6-bisphosphate ldolase from human muscle has been determined at 3.0 A resolution by X-ray crystal- 
lography. The active protein is a tetramer of 4 identical subunits each of which is composed of an ~ght-stands a/$-barrel structure. The lysine 
residue responsible for SchifI base formation with the substrate is located near the centre of the barrel in the middle of the sixth p-strand. While 
the overall topology of the a/B-barrel is very similar to those found in several other enzymes, the distribution of charged residues inside the core 
of the barrel seems distinct. The quatemary fold of human muscle aldolase uses interfacial regions also involved in the subunit association of other 
a/p-barrel proteins found in glycolysis, but exploits these regions in a manner not seen previously. 
a/&Barrel; Crystal structure; Isozyme; Schiff base; Type I aldolase; (Human muscle) 
1. INTRODUCTION 
Fructose-l ,6-bisphosphate aldolase (EC 4.1.2.13) is 
the glycolytic enzyme responsible for catalysing the 
reversible aldol cleavage of fructose-l ,6-bisphosphate 
into the triose phosphates, D-glyceraldehyde 3-phos- 
phate and dihydroxyacetone phosphate. The active en- 
zyme is a tetramer of 4 identical subunits each with a 
relative molecular mass of 36000. It is a representative 
of the class I aldolases which, unlike class II aldolases 
(for review, see [I]), do not exploit metal ions in the 
catalytic process. The catalytic cycle of the enzyme in- 
volves the formation of a Schiff base intermediate with 
a lysine residue. The reaction mechanism of class I 
aldolases has been extensively studied and the aldol 
cleavage has been shown to proceed by a number of 
distinct enzyme-substrate intermediates [11, In mam- 
malian systems there are 3 isozymes, A, B and C, which 
are expressed in a characteristic pattern [2]. Aldolase A 
is produced in the developing embryo and several 
tissues of the adult, most notably in muscle tissue, 
where it may represent up to 5% of the total cellular 
protein [3]. The amino acid sequence of human muscle 
aldolase has been determined [4] and is highly 
homologous to that of the rabbit muscle enzyme [5]. 
The low resolution (6 A) structure of human muscle 
aldolase [6] and the medium resolution (2.7 A) structure 
of the rabbit muscle [7,81 enzyme have been reported. 
Here we describe the structure determination of human 
muscle aldolase (ALD) at 3.0 A resolution. 
It is evident from structural studies on both the 
human and rabbit muscle enzymes that the core of the 
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aldolase subunit is based on a cr/&barrel arrangement. 
The a/&barrel structure was first observed in the struc- 
ture determination of triose phosphate isomerase (TIM) 
191. This folding motif has since been recognised in 
many systems including the A-domain of pyruvate 
kinase (PK) [IO], KPDG aldolase [ 111, taka-amylase 
[ 121 and glycolate oxidase [ 131. The motif is made up of 
eight cr/,& supersecondary structure units related by 
pseudo &fold symmetry. Muirhead [14] has made a 
detailed comparison of several &,&barrel proteins and 
has concluded that their overafl topologies are very 
similar even though there is little or no sequence 
homology between them. Lesk and his colleagues [15] 
have carried this analysis further by analysing the 
geometry of several c/&barrel proteins together with 
the positioning of side chains associated with the core of 
each barrel. This work has revealed a simple pattern 
which elegantly describes the packing of side chains 
within the barrel. Here we make use of these general 
observations in the analysis of the structure of this type 
I aldolase from human muscle. 
2. EXPERIMENTAL 
2.1. Protein purification and crystaltisation 
The protein was extracted from homogenised human leg muscle 
and purified by ammonium sulphate precipitation and column 
chromatography procedures according to Scopes f16f. Crystals were 
prepared for the 3.0 A data collection by the batch method as already 
described [6,17]. The protein concentration was approximately 7 
mg/ml in 300 mM imidazole, 50 mM KCl, 3 mM Mg acetate, 0.1 mM 
EDTA at pH 6.5 and ammonium sulphate at 440 g/l. The crystals 
grow as hexagonal bipyramids and belong to the space group P&22 
with a = b = 96.5 A; c = 167 A. Density measurements show that 
the unit cell contains 3 tetrameric molecules and therefore there is just 
one monomer in the asymmetric unit. These crystals are similar in 
habit and unit cell dimensions to those reported earlier for rabbit en- 
zyme [18] but, unlike those crystals, the crystals from human muscle 
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are stable to X-ray radiation. A mercuric derivative for use in isomor- 
phous replacement studies was prepared by soaking crystals in 0.1 
mM gchloromercuribenzoate (@MB) for 3 days. A platinum 
derivative was also prepared by soaking crystals in solutions contain- 
ing 1 mM K2PtCL for 16 h prior to irradiation. 
2.2. Data collection and processing 
Diffraction data to 3.0 A resolution were recorded with an Arndt 
and Wonacott rotation camera using a sealed tube X-ray source. 
Three crystals were needed to collect the individual data sets, each of 
which comprised some 7080% of the unique diffraction range. The 
digitised film data were processed using the MOSFLM suite of pro- 
grams [PI]. The native and derivative data sets were of similar quality 
producing merging statistics (on intensity) close to 7%. The relative 
changes in structure factor amplitudes between the native and 
derivative data set were near to 14% in both cases. Patterson maps 
were calculated in the usual way and the heavy atom positions so 
determined were refined using both least-squares and different 
Fourier procedures. The positions and occupancies of the heavy metal 
binding sites are presented in table 1. When the isomorphous data 
were used to phase the native structure factors [20] the average figure 
of merit for those reflexions phased by both derivatives was 0.72. 
2.3. Fourier maps 
The symmetry of space group P&22 means that there are only 4 
possible sets of positions at which a tetramer with 222-fold molecular 
symmetry can be accommodated in the unit cell. Examination of the 
distribution of electron density at and around each of the possible 
centres revealed that one of the tetramers must be centered at (l/2,0, 
l/2). With this information it was possible to describe tentative 
subunit boundaries [6]. Whilst the course of the polypeptide chain 
could be traced in several regions [17], the map was not of sufficient 
quality to reveal the overall molecular architecture of the aldolase 
subunit. In retrospect it is evident that the rather poor quality of the 
map was due to the fact that only half of the native reflexions were 
phased by both the mercury and platinum derivatives. 
2.4. Molecular replacemeni 
As described earlier the amino acid sequence of rabbit muscle 
aldolase is highly homologous to that of the human muscle enzyme 
and, as such, the structure of this protein represents agood model for 
molecular replacement studies on human muscle aldolase. As the 
coordinates of the published structure of the rabbit muscle enzyme 
have not been deposited with the Brookhaven Database, the 
stereographic diagrams contained in the paper describing this work 
[8] were enlarged and then digitised using a flat bed x-y recorder. The 
two sets of tw~dimensional coordinate data were then converted into 
a three-dimensional coordinate list using a modified version of the 
program STEREO available from the Brookhaven Data Bank [Zl]. 
The resulting C, coordinates were then used, together with the se- 
quence of the human muscle aldolase [4], to generate an atomic model 
using the interactive computer graphics program FRODO [U]. 
The molecular centre information derived from the MIR maps 
described in section 2.3 limits the number of possible orientations for 
the aldolase tetramer. The 6 possible arrangements correspond to dif- 
Table 1 
The relative occupancies and the fractional coordinates of the major 
platinum and mercury binding sites 
Derivative Occupancy X Y z 
Pt 1 1.0453 0.3567 0.6547 0.0693 
2 0.9044 0.0011 0.4252 0.1623 
p-CMB 1 0.9045 0.1754 0.6242 0.9954 
2 0.4741 0.075 1 0.8942 0.0739 
The unit cell dimensions and the details of the heavy metal com- 
pounds used are detailed in the text 
ferent alignments of the 3 molecular dyad axes with respect to the 
crystallographic a*, b and c axes. The aldolase tetramer has dimen- 
sions of approximately 90 x 90 x 65 A [6,7] along the molecular 
axes. Given that 3 tetramers must be accommodated within the unit 
cell and that the crystallographic -axis is just 167 A long, it follows 
that the short dimension of the tetramer must be aligned parallel with 
the unique axis of the crystal. This leaves just two ways of placing the 
subunit in the unit cell. The correctness of the starting model was evi- 
dent from a consideration of the locations of the heavy metal binding 
sites detailed in table 1. In the correct starting model all 3 methionine 
residues were within 5 A of platinum binding sites and cysteine 239 
was close to the major mercury binding site. 
3. RESULTS AND DISCUSSION 
The initial position of the subunit model was refined 
by an R-factor search procedure using the programs 
CADLCF and TSEARCH [ 191. Small translation ad- 
justments were made and the starting model was refined 
by X-ray restrained energy minimisation using the 
XPLOR package [23]. During the course of 400 cycles 
of refinement he geometry of the model improved con- 
siderably and the agreement residual dropped from 
49% to 32% with RMS deviations from ideality of 0.03 
A and 5” for bond lengths and angles, respectively. 
3.1. The subunit model 
The core of the human aldolase structure is made up 
of alternating &strands and a-helices as is shown in 
fig. 1. The CY/@ units are arranged with the helices run- 
ning approximately antiparallel with the &strands, so 
that together the 8 units make up a parallel a/&barrel 
with the helices packed around the outside. There are 4 
additional helices, 3 of which occur as inserts between 
the classical strand and helix components making up 
these particular CJY’~ units. These extra helices are 
located after P-strands a, b and h. In common with 
KPDG aldolase, the human muscle aldolase also has an 
additional N-terminal helix (I in fig. 1) which effectively 
closes off the amino end of the a/,&barrel. There are 6 
helices running antiparallel to p-strands which have 
charged residues at their termini. Of these helices, A2, 
B2, C, F and G have charged side chains that would 
form stabilising interactions with the helix dipoles [24]. 
The cross-section of the barrel is not quite circular but 
is less eccentric than the u/&barrel found in TIM 191. 
Although the &strands are generally six or more 
residues long, only 3 of these can be regarded as form- 
ing an integral part of the barrel structure. These 3 
residues occur at the same height relative to the barrel 
axis in all eight strands and they all contribute to a 
hydrogen bonded net around the barrel. The core of the 
barrel is made up from 12 residues, two are provided 
from each of the first, third, fifth and seventh strands 
while the second, fourth, sixth and eighth strands con- 
tribute third, just one amino acid each. These residues 
are Ala-31, Asp-33, Ile-77, Gly-105, Lys-107, Lys-146, 
Be-185, Glu-187, Lys-229, Thr-268, Leu-270 and 
Ser300. Of these 12 amino acids, 5 have charged side 
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Fig. 1. A stereo diagram of a single subunit of human muscle aldolase. The &strands are shown as arrows and are labelled with lower-case letters, 
while the ru-helices are drawn as cylinders and are labelled in upper-case. The connecting regions between secondary structure units are shown as 
lines between successive Ccu positions with arrowheads indicating the direction of the polypeptide chain. The monomer is orientated so that the 
readers line of vision is along the molecular two-fold axis which lies parallel to the direction of the crystallographic 6-fold. 
chains, this value compares with just two charged 
residues contributing to the barrel structure of glycolate 
oxidase and none at all in the case of the TIM barrel 
[ 151. The active site of the enzyme is made up from 
several of these charged residues as was first pointed 
out by Sygusch et al. [S]. In contrast the active sites of 
both TIM and PK occur much more toward the car- 
boxy1 ends of the P-strands. 
3.2. Quaternary structure 
The aldolase subunits are packed in a somewhat flat- 
tened tetrahedral-like configuration. Each subunit 
makes significant interactions with just two of its 
neighbours. The contact regions are largely hydro- 
phobic in nature. The more extensive of the two inter- 
faces is made up by the interaction of side chains from 
helices E and F from adjacent subunits. These two 
subunits are related by a dyad axis which lies in the 
plane approximately perpendicular to the axis of the 
barrel. The packing arrangement of this subunit inter- 
face is shown in fig.2. The relationship between the two 
subunits is such that the two pairs of symmetry-related 
helices are approximately antiparallel. Helix E interacts 
with its symmetry equivalent *E along virtually all its 
length, while F and *F contact at only their carboxyl 
ends. Helix E provides the only example in aldolase of 
a helix with charged side chains at its ends which ac- 
centuate the helix dipole. Presumably the antiparallel 
packing of this helix with its symmetry equivalent will 
then be additionaly stabilised by electrostatic interac- 
tions [24]. The structure of the PK tetramer is such that 
it also makes a major subunit contact at this edge of the 
barrel between symmetry-related flanking helices. In 
the case of PK, however, the dyad axis is positioned 
such that it runs nearly parallel with the axis of the bar- 
rel with the result that the main packing component 
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consists of the almost perpendicular crossing of the 7th 
flanking helix with its symmetry equivalent [25]. 
The less extensive subunit interface in the ALD 
tetramer is formed by both the loop connecting strand 
c with helix C and the D helix from the two subunits 
which are related by the second dyad in the plane 
perpendicular to the barrel axis (as is shown in fig.3). 
Inspection of the interface of the TIM dimer reveals 
that both subunits contribute a loop, each of which ef- 
fectively encircles a methionine residue associated with 
the other subunit. This loop in TIM joins the third 
strand and the third helix of the &,&barrel [9]. The do- 
main structure of PK is arranged so that the second do- 
main occurs as an insertion between the third strand 
and the third helix of the barrel. These observations 
concerning the connection within the third cr/fl unit 
from these 3 proteins is noteworthy from two view- 
points. Firstly the &&barrel motif has pseudo S-fold 
symmetry such that none of the 8 ways of superimpos- 
ing pairs of barrel structures are clearly better than any 
other [26]. In the cases of TIM, ALD and PK, however, 
all 3 proteins have subunit/domain interfaces involving 
the connecting region between the third strand and 
third helix of the barrel. Secondly, in TIM this loop 
region plays an essential role in the formation of the ac- 
tive site of the second subunit of the dimer whereas 
there is no such catalytic role for the corresponding 
loop in ALD. Indeed it has been shown that monomeric 
aldolase retains approximately 50% of the catalytic ac- 
tivity of the tetrameric form [27]. 
The structure reported here for human muscle 
aldolase is largely similar to that reported for the rabbit 
muscle enzyme. In the absence of a set of refined coor- 
dinates for the rabbit muscle enzyme it is not possible to 
carry out a detailed analysis of the differences which 
might exist between the two structures. We have recent- 
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Fig.Z. A stereo diagram of the components making up the more extensive of the two dimer interfaces. The subunit which is equivalent o the full 
monomer shown in fig. 1, is drawn in heavier lines than that of its symmetry-related counterpart. Symmetry-related helices are marked with an 
asterisk. The molecular dyad axis relating the subunits is coincident with the crystallographic a* axis and lies vertically in the plane of the diagram. 
ly collected a complete set of diffraction data to a bloodstream depend entirely on glycolysis for their 
resolution of 2.2 A from a single crystal of human mus- energy supply, enzymes in this pathway present an ob- 
cle aldolase using the Daresbury synchroton radiation vious target for chemotherapeutic attack. This prospect 
source. The quality of these data is better than that col- is enhanced by the fact that these organisms gather 
lected by sealed X-ray source and will greatly facilitate many of their glycolytic enzymes into a microbody call- 
the refinement of the human aldolase structure, It is an- ed a glycosome f2!4. Given now the structure of the 
ticipated that this work, together with results obtained human muscle aldolase and the sequence of the 
using crystals prepared from protein whose active site trypanosome aldolase [30], it may well prove possible to 
lysine has been modified, will help provide detailed in- produce drugs designed to specifically inhibit the 
formation on the catalytic mechanism af the enzyme, glycosomal aldolase function. 
Recently, there has been much interest in the design 
of specific drugs for the control of parasitic protozoan 
infections of both domestic animals and humans. In 
particular the African trypanosomes, which are respon- 
sible for causing sleeping sickness, have been studied in 
some detail [28]. As trypanosomes in the mammalian 
Coordinates for the human muscle aldolase will be 
deposited with the Brookhaven protein structure base 
after refinement of the structure at 2.2 A resolution. 
Crystallographic studies on type II aldolases from 
Bacillus stewothermophilus and Escherichia coli are 
also in progress. 
Fig3 A stereo diagram of the less extensive of the dimer interfaces. The moiecuhr dyad axis relating the two subunits is coincident with the 
c~st~lo~a~bic b axis and lies horizontally in the plane of the diagram. The figures presented here were prepared using the LESK program &ask, 
A.K. and Hardman, A.D. (1982f Science 216, 439-540). 
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